Comprehending depression through proteomics

International Journal of Neuropsychopharmacology

Volumn 15, Issue 10, 2012, Pages 1373-1374

  Martins De Souza, Daniel ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN PROTEIN; CARBONATE DEHYDRATASE; COLLAPSIN RESPONSE MEDIATOR PROTEIN 2; PROTEOME;

CEREBROSPINAL FLUID; DISEASE SEVERITY; DOWN REGULATION; ENERGY METABOLISM; ENVIRONMENTAL FACTOR; FRONTAL CORTEX; GENETIC PREDISPOSITION; HUMAN; MAJOR DEPRESSION; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; METABOLITE; MOLECULAR BIOLOGY; NOTE; PATHOPHYSIOLOGY; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEOMICS; PSYCHOSIS; SCHIZOPHRENIA; SYNAPTIC TRANSMISSION; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

COMPREHENSION; DEPRESSION; DEPRESSIVE DISORDER, MAJOR; HUMANS; PROTEOMICS;

EID: 84867263931     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S146114571200034X     Document Type: Note

References (12)

1. Beasley CL, Pennington K, Behan A, Wait R, et al. (2006). Proteomic analysis of the anterior cingulate cortex in the major psychiatric disorders : evidence for diseaseassociated changes. Proteomics 6, 3414-3425.
2. Ditzen C, Tang N, Jastorff AM, Teplytska L, et al. (2012). Cerebrospinal fluid biomarkers for major depression confirm relevance of associated pathophysiology. Neuropsychopharmacology 37, 1013-1025.
3. Fava M, Kendler KS (2000). Major depressive disorder. Neuron 28, 335-341.
4. Goltser-Dubner T, Galili-Weisstub E, Segman RH (2010). Genetics of unipolar major depressive disorder. Israel Journal of Psychiatry and Related Sciences 47, 72-82.
5. Johnston-Wilson NL, Sims CD, Hofmann JP, Anderson L, et al. (2000). Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. The Stanley Neuropathology Consortium. Molecular Psychiatry 5, 142-149.
6. Martins-de-Souza D, Guest PC, Harris LW, Vanattou-Saifoudine N, et al. (2012a). Identification of proteomic signatures associated with depression and psychotic depression in post-mortem brains from major depression patients. Translational Psychiatry 2, e87.
7. Martins-de-Souza D, Guest PC, Vanattou-Saifoudine N, Rahmoune H, et al. (2012b). Phosphoproteomic differences in major depressive disorder postmortem brains indicate effects on synaptic function. European Archives of Psychiatry and Clinical Neuroscience. Published online : 21 February 2012. doi:10.1007/s00406-012-0301-3.
8. Martins-de-Souza D, Harris LW, Guest PC, Turck CW, et al. (2010). The role of proteomics in depression research. European Archives of Psychiatry and Clinical Neuroscience 260, 499-506.
9. Mehta D, Menke A, Binder EB (2010). Gene expression studies in major depression. Current Psychiatry Reports 12, 135-144.
10. Muller MB, Holsboer F (2006). Mice with mutations in the HPA-system as models for symptoms of depression. Biological Psychiatry 59, 1104-1115.
11. Wilkins MR, Pasquali C, Appel RD, Ou K, et al. (1996). From proteins to proteomes : large scale protein identification by two-dimensional electrophoresis and amino acid analysis. Biotechnology (NY) 14, 61-65.
12. Xu HB, Zhang RF, Luo D, Zhou Y, et al. (2012). Comparative proteomic analysis of plasma from major depressive patients : identification of proteins associated with lipid metabolism and immunoregulation. International Journal of Neuropsychopharmacology. doi :S1461145712000302.